Фармакоэкономика (Dec 2015)

NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL

  • D. V. Blinov

DOI
https://doi.org/10.17749/2070-4909.2015.8.3.014-019
Journal volume & issue
Vol. 8, no. 3
pp. 14 – 19

Abstract

Read online

Introduction. Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized as an important and common public health problem that can lead to cirrhosis and hepatic failure (hepatocellular carcinoma – HCC). It may be the most prevalent liver disease. However knowledge of the epidemiology is limited. Most data came from studies conducted in Northern America, Western Europe, Japan and China. A first disease registry in NAFLD (DIREG_L_01903) was performed in 2007 in Russia. This study showed high prevalence of NAFLD within the GP-s patient flow (27%). These findings encourage to conduct a larger sample size study to evaluate the real prevalence of NAFLD in the Russian population and if this prevalence of NAFLD patients has changed in the last 7 years.

Keywords